乳腺良性肿块患者EnCor微创旋切术后血肿发生状况及影响因素

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (520 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the incidence and influencing factors of hematoma in benign breast lymp patients after EnCor minimally invasive rotatectomy. Methods A total of 80 patients with benign breast lymps admitted to 17th Metallurgical Hospital from January 2019 to June 2021 were selected. All patients were treated with EnCor minimally invasive rotatectomy. The occurrence of postoperative hematoma was recorded, and the influencing factors of postoperative hematoma were analyzed. Results Postoperative hematoma occurred in six cases of the 80 patients, with an incidence of 7.50%. Univariate analysis showed that there were statistically significant differences in the incidence of hematoma among patients with different number of lumps, depth of lumps, number of incisions, Adler blood supply grade, and postoperative bandage compression time (P < 0.05). The multivariate analysis showed that the number of lumps, the depth of lumps, the number of incisions, the Adler blood supply grade, and postoperative bandage compression time were all influencing factors for the occurrence of hematoma after EnCor minimally invasive rotatectomy (OR ＞ 1, P < 0.05). Conclusion The number of lumps, the depth of lumps, the number of incisions, the Adler blood supply grading, and postoperative bandage compression time are important risk factors for the occurrence of hematoma after EnCor minimally invasive rotatectomy in patients with benign breast lymps.

Key words： Breast Benign lymp EnCor minimally invasive rotatectomy Hematoma Influencing factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Pei LIU Shangjun ZHANG Ruhui

Cite this article:

WANG Pei LIU Shangjun ZHANG Ruhui. The incidence and influencing factors of hematoma after EnCor minimally invasive rotatectomy in patients with benign breast lymp[J]. 中国医药导报, 2022, 19(23): 97-99,108.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I23/97

[1] Stachs A，Stubert J，Reimer T，et al. Benign Breast Disease in Women [J]. Dtsch Arztebl Int，2019，116（33/34）： 565-574.
[2] Waldman RA，Finch J，Grant-Kels JM，et al. Skin diseases of the breast and nipple： Benign and malignant tumors [J]. J Am Acad Dermatol，2019，80（6）： 1467-1481.
[3] Bozzini A，Cassano E，Raciti D，et al. Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices： Mammotome and Elite [J]. Clin Breast Cancer，2018， 18（6）：e1277-e1282.
[4] 任辉.EnCor手术治疗乳腺脓肿患者的临床疗效及对ICAM-1水平的影响[J].医学临床研究，2020，37（3）：422-424.
[5] 栗辰.真空辅助微创旋切系统在乳腺良性疾病中的应用进展[J].中国微创外科杂志，2020，26（3）：265-267，271.
[6] 武晓娜.超声引导下麦默通微创旋切系统治疗乳腺良性肿瘤的应用价值[J].山西医药杂志，2021，50（5）：818-820.
[7] 谢幸，苟文丽.妇产科学[M].北京：人民卫生出版社，2013：257-260.
[8] 陈孝平，汪建平.外科学[M].8版.北京：人民卫生出版社，2014：432-433.
[9] 翁沛华.VTQ技术对乳腺肿块良恶性的准确性及诊断价值[J].中国医药科学，2020，10（4）：247-250.
[10] Gottschau M，Jensen A，Reinholdt K，et al. Risk of breast cancer among women with benign ovarian tumors：a Danish nationwide cohort study [J]. Breast Cancer Res Treat，2019，178（1）：199-205.
[11] 陈光新，李立，李晓华.乳外微小切口乳腺良性实体肿瘤切除术对提高术后乳房美容效果的临床研究[J].中国医药科学，2021，11（10）：172-175.
[12] Kuehner G，Darbinian J，Habel L，et al. Benign Papillary Breast Mass Lesions： Favorable Outcomes with Surgical Excision or Imaging Surveillance [J]. Ann Surg Oncol，2019，26（6）：1695-1703.
[13] 童庆松，章晓兰，蔡杜娟，等.超声引导下EnCor微创旋切术与开放切除术治疗乳腺肿块的疗效比较[J].川北医学院学报，2021，36（1）：60-63.
[14] Choi HY，Kim SM，Jang M，et al. Benign Breast Papilloma without Atypia： Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up [J]. Radiology，2019，293（1）：72-80.
[15] 王力，肖献秋，芮小平.超声引导下EnCor乳腺微创手术不同操作方法的临床应用[J].东南国防医药，2020， 22（6）：612-616.
[16] 黄红伟，岳梦楠，王小兰.观察超声引导下乳腺肿物微创旋切围手术期护理效果[J].中华肿瘤防治杂志，2020，27（S1）：203-204.
[17] 唐杰，何芬，王曦，等.超声引导下乳腺结节Mammotome微创旋切术的临床价值[J].西北国防医学杂志，2021， 42（6）：508-510.
[18] Moynihan A，Quinn EM，Smith CS，et al. Benign breast papilloma： Is surgical excision necessary? [J]. Breast J，2020，26（4）： 705-710.
[19] 董云云，张慧明，史宪全，等.超声引导下乳腺良性结节微创旋切术后血肿预后及影响因素分析[J].中国医学装备，2021，18（1）：81-85.
[20] 谢雨芹，邓爽，邓倩，等.超声引导下微创乳腺麦默通旋切系统治疗多发性乳腺肿块临床分析[J].中国临床医生杂志，2021，49（1）：79-81.
[21] 沈亚琴.乳腺良性肿瘤超声引导下微创旋切术围手术期护理[J].中国基层医药，2019，26（16）：2038-2040.
[22] 丁国乾，高银光，葛智成，等.超声引导下麦默通微创旋切术在1036例乳腺肿物切除中的应用[J].临床和实验医学杂志，2019，18（12）：1309-1312.
[23] 王超，张乘，冯海湛，等.麦默通微创旋切术加置引流对乳腺良性肿物患者术后恢复与并发症的影响[J].实用医学杂志，2018，34（11）：1881-1884，1888.
[24] 杨迎旭，田思齐，钱跃军，等.麦默通微创旋切术附加小切口与传统手术切除乳房巨大良性肿瘤的比较[J].中国微创外科杂志，2019，19（9）：803-807.
[25] 钱宇峰，童东明，昌莉莉.乳腺微创旋切术与传统开放术治疗乳腺良性肿块术中情况、术后疼痛、瘢痕及并发症的对比分析[J].中国妇幼保健，2018，33（5）：1170-1172.